Colt Egelston (@coltegelston) 's Twitter Profile
Colt Egelston

@coltegelston

Immuno-Oncology at City of Hope.
Lover of beagles and a long run.

ID: 30348276

calendar_today11-04-2009 00:07:54

1,1K Tweet

267 Followers

1,1K Following

Colt Egelston (@coltegelston) 's Twitter Profile Photo

One of many reasons I'm voting for Eunisses Hernandez for CD1: support of better bike infrastructure, which the incumbent has failed to do! Succinctly put by the Los Angeles Times #LosAngeles

One of many reasons I'm voting for <a href="/EunissesH/">Eunisses Hernandez</a> for CD1: support of better bike infrastructure, which the incumbent has failed to do! Succinctly put by the <a href="/latimes/">Los Angeles Times</a> #LosAngeles
Los Angeles Election Results (@laelectionbot) 's Twitter Profile Photo

Election Update- Tue Jun 14 2022 23:11:01 LOS ANGELES CITY PRIMARY NOMINATING ELECTION Member of the City Council, 1st District EUNISSES HERNANDEZ - 50.6% (11354 votes) GILBERT "GIL" CEDILLO - 49.3% (11062 votes)

Santiago Carmona 🧬 🖥️ carmonation.bsky.social (@carmonation) 's Twitter Profile Photo

Love Singlecell? Learn together with Jean Fan Dr. Jean Fan, Ido Amit IdoAmitLab, Dominic Grün Dominic Grün, Fabian Theis Fabian Theis, Sohrab Shah Sohrab Shah and many more at [BC]2 Consider submitting your abstract by next Wednesday and join us in Basel in September!

Dr. Marwan G. Fakih (@mgfakih) 's Twitter Profile Photo

Proud to lead this work. RIN study was a single center trial at City of Hope. More evidence that IO combinations can be of great value in MSS CRC without liver metastatic disease. Results appear >> than REGONIVO. Hot off the press in JAMA Oncology today! jamanetwork.com/journals/jamao…

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Elacestrant, alpelisib, capivasertib, everolimus, ribo maintenance. A rapidly expanding arsenal to fill the critical gap between CDK4/6-inh and chemo. Check our latest open access review, led by Abhenil Mittal, for a deep dive into this evolving landscape! mdpi.com/2072-6694/15/7…

Elacestrant, alpelisib, capivasertib, everolimus, ribo maintenance. A rapidly expanding arsenal to fill the critical gap between CDK4/6-inh and chemo. Check our latest open access review, led by <a href="/abhenilmittal/">Abhenil Mittal</a>, for a deep dive into this evolving landscape!
mdpi.com/2072-6694/15/7…
Dr Sarah Sammons (@drsarahsam) 's Twitter Profile Photo

Thank you #ShannenDoherty for sharing your experience with breast cancer brain metastases, a common occurrence in #MBC. Awareness can do nothing but help! We try hard to increase awareness, clinical research and industry engagement in this space. #bcsm people.com/shannen-dohert…

Sara McArdle (@saramcardle1) 's Twitter Profile Photo

📢*Announcing 2 Image Analysis Training Courses!* 1) QuPath Training Course- October 9-11, San Diego, CA tiny.cc/QuPathCourseFl… 2) Quantitative BioImaging Multiplex Image Analysis- October 12-13, San Diego, CA quantitativebioimaging.com/qbi2023/mia202…

World Scientific (@worldscientific) 's Twitter Profile Photo

Welcoming #WSARCI to the @WorldScientific Annual Review portfolio! Publishing research across the field of immuno-oncology. 📢Now Open for Submissions Editors-in-Chief: Joe Yeong and Joline Lim #cancer #cancerimmunology #Immunotherapy

Dr. Marwan G. Fakih (@mgfakih) 's Twitter Profile Photo

Immunotherapy Response in Microsatellite Stable Metastatic Colorectal Cancer Is Influenced by Site of Metastases - European Journal of Cancer ejcancer.com/article/S0959-… -See our comprehensive analysis of site of metastases and response to CPI/TKI in MSS CRC

Akoya Biosciences (@akoyabio) 's Twitter Profile Photo

Hear from Cure Cancer's 2023 Researcher of the Year, Arutha K, about how #singlecell #spatialphenotyping is an invaluable tool when characterizing the #tumormicroenvironment & how this technology can be used to develop consistently predictive biomarkers. bit.ly/3rBJgWA

Akoya Biosciences (@akoyabio) 's Twitter Profile Photo

🌏 We're going west for the next stop on the #IlluminationTour2024: SAN DIEGO. Join us at Green Acres Campus Point on May 22 to hear from Colt Egelston of City of Hope, Nathan Roscoe of J&J Innovative Medicine + Akoya experts for discussion, networking & free lunch. bit.ly/3WspObN

🌏 We're going west for the next stop on the #IlluminationTour2024: SAN DIEGO. 

Join us at Green Acres Campus Point on May 22 to hear from <a href="/ColtEgelston/">Colt Egelston</a> of <a href="/cityofhope/">City of Hope</a>, Nathan Roscoe of <a href="/JNJInnovMed/">J&J Innovative Medicine</a> + Akoya experts for discussion, networking &amp; free lunch. bit.ly/3WspObN
Akoya Biosciences (@akoyabio) 's Twitter Profile Photo

🔆 Are you ready, San Diego? The #IlluminationTour will be coming your way on Wednesday! Hear about the latest advances from Akoya, plus #spatialbiology applications in #pathology & #oncology from experts: Colt Egelston of City of Hope & Nathan Roscoe of J&J Innovative Medicine ❗ Nab one

🔆 Are you ready, San Diego? The #IlluminationTour will be coming your way on Wednesday! Hear about the latest advances from Akoya, plus #spatialbiology applications in #pathology &amp; #oncology from experts: <a href="/ColtEgelston/">Colt Egelston</a> of <a href="/cityofhope/">City of Hope</a> &amp; Nathan Roscoe of <a href="/JNJInnovMed/">J&J Innovative Medicine</a>

❗ Nab one
Saul “Cancer Asskicker” Priceman (@saulpriceman) 's Twitter Profile Photo

Proud of our work published today in Nature Medicine, sharing results from our phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC. Big collaborations work Tanya Dorff @stephenforman Peter Kuhn Lior Pachter ! Thank you Prostate Cancer Foundation for your support! nature.com/articles/s4159…

Heather McGee, MD PhD (@hmcgeemdphd) 's Twitter Profile Photo

I am excited to share a discovery from a large international collaboration led by City of Hope published on PubMed this week: Genetic Variation and Regulation of MICA Alters Natural Killer Cell-Mediated Immunosurveillance in Early-Onset Colorectal Cancer medrxiv.org/content/10.110…